Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wilhelm

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Chemotherapy|August 1, 2008
Reduction of HLA-DR+ lymphocytes after treatment with enzastaurin in patients with metastatic thyroid cancerManfred Smetak, Karin Weigang-Koehler, Axel Hanauske, et al.
Journal of Translational Medicine|February 18, 2014
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cellsMartin Wilhelm, Manfred Smetak, Kerstin Schaefer-Eckart, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 19, 2019
Improving Immunotherapy Against B-Cell Malignancies Using γδ T-Cell-specific Stimulation and Therapeutic Monoclonal AntibodiesTimm Hoeres, Dominik Pretscher, Elisabeth Holzmann, et al.
Annals of Hematology|November 25, 2003
Decreased frequency of HLA-B35 in patients with gastric MALT lymphomaPeter Reimer, Wolfgang Fischbach, Maria-Elisabeth Goebeler, et al.
Frontiers in Public Health|May 2, 2022
Specialized Biopsychosocial Care in Inpatient Somatic Medicine Units-A Pilot StudyPaul Köbler, Eva K Krauss-Köstler, Barbara Stein, et al.
The Journal of Biological Chemistry|October 25, 2001
Escherichia coli produces phosphoantigens activating human gamma delta T cellsJuliane Feurle, Eric Espinosa, Susanne Eckstein, et al.
Journal of Geriatric Psychiatry and Neurology|June 6, 2007
FMR1 alleles in Parkinson's disease: relation to cognitive decline and hallucinations, a longitudinal studyMartin Wilhelm Kurz, Anna Melissa Schlitter, Yvonne Klenk, et al.
Haematologica|October 13, 2005
Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study GroupManuela A Bergmann, Maria E Goebeler, Michael Herold, et al.
Immunobiology|October 16, 2022
Immune activating and inhibiting effects of calcitriol on γδ T cells and NK cellsAnna Bold, Heike Gross, Elisabeth Holzmann, et al.
Leukemia & Lymphoma|March 29, 2011
Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphomaPeter Borchmann, Raoul Herbrecht, Martin Wilhelm, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Chemotherapy|August 1, 2008
Reduction of HLA-DR+ lymphocytes after treatment with enzastaurin in patients with metastatic thyroid cancerManfred Smetak, Karin Weigang-Koehler, Axel Hanauske, et al.
Journal of Translational Medicine|February 18, 2014
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cellsMartin Wilhelm, Manfred Smetak, Kerstin Schaefer-Eckart, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 19, 2019
Improving Immunotherapy Against B-Cell Malignancies Using γδ T-Cell-specific Stimulation and Therapeutic Monoclonal AntibodiesTimm Hoeres, Dominik Pretscher, Elisabeth Holzmann, et al.
Annals of Hematology|November 25, 2003
Decreased frequency of HLA-B35 in patients with gastric MALT lymphomaPeter Reimer, Wolfgang Fischbach, Maria-Elisabeth Goebeler, et al.
Frontiers in Public Health|May 2, 2022
Specialized Biopsychosocial Care in Inpatient Somatic Medicine Units-A Pilot StudyPaul Köbler, Eva K Krauss-Köstler, Barbara Stein, et al.
The Journal of Biological Chemistry|October 25, 2001
Escherichia coli produces phosphoantigens activating human gamma delta T cellsJuliane Feurle, Eric Espinosa, Susanne Eckstein, et al.
Journal of Geriatric Psychiatry and Neurology|June 6, 2007
FMR1 alleles in Parkinson's disease: relation to cognitive decline and hallucinations, a longitudinal studyMartin Wilhelm Kurz, Anna Melissa Schlitter, Yvonne Klenk, et al.
Haematologica|October 13, 2005
Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study GroupManuela A Bergmann, Maria E Goebeler, Michael Herold, et al.
Immunobiology|October 16, 2022
Immune activating and inhibiting effects of calcitriol on γδ T cells and NK cellsAnna Bold, Heike Gross, Elisabeth Holzmann, et al.
Leukemia & Lymphoma|March 29, 2011
Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphomaPeter Borchmann, Raoul Herbrecht, Martin Wilhelm, et al.
Pageof 10